Absci Corp ABSI 深 沪
已收盘 11-13 16:00:00 美东时间
8.45
-0.685
-7.50%
华盛通- 最 高9.40
- 今 开9.37
- 成交量 548.58万股
- 最 低 8.32
- 昨 收 9.135
- 总市值 145.01万
- 52周最高 12.5449
- 市盈率 静 --
- 换手率 3.20%
- 52周最低 2.24
- 委 比 20.00%
- 总股本 0.00亿
- 历史最高 31.53
- 量 比 1.23
- 振 幅 11.82%
- 历史最低 1.1111
- 每 手 1
- 风险率 3.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Absci Earnings Call: Hair-Loss Data Nears
Absci Corp. (($ABSI)) has held its Q3 earnings call. Read on for the main highl...
11-13 08:21
Absci Q3 EPS $(0.19) Beats $(0.20) Estimate, Sales $304.000K Miss $727.125K Estimate
Absci (NASDAQ:ABSI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 5 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $304.000 thousand which missed t...
11-12 20:08
Absci Appoints Gerry Muhle as Chief Commercial Officer to Build Category-Defining Brands for ABS-201 and Its Broader Pipeline
Absci Corporation appoints Gerry Muhle as Chief Commercial Officer, bringing over 25 years of experience in commercializing prescription medicines and building consumer brands. Muhle previously led global product strategy at Galderma, driving growth for iconic brands and launching new therapies. At Allergan/AbbVie, he managed aesthetics portfolios including Botox and Juvéderm. His expertise in connecting prescription medicines with consumer skinc...
11-12 12:00
美股大行评级 | 潜在涨幅1112.12%！Canaccord Genuity上调Wave Life Sciences目标价至44美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences"买入"评级，目标价从42美元升至44美元；Canaccord Genuity：维持Pharming Group"买入"评级，目标价从38美元升至41美元
10-30 12:30
Jefferies Initiates Coverage On Absci with Buy Rating, Announces Price Target of $14
Jefferies analyst Andrew Tsai initiates coverage on Absci (NASDAQ:ABSI) with a Buy rating and announces Price Target of $14.
10-30 06:26
Absci to Participate in Upcoming Investor Conferences
Absci Corporation will participate in three upcoming investor conferences: the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, the 2026 Jefferies Global Healthcare Conference in London on November 18, and the 9th Annual Evercore Healthcare Conference in Coral Gables, FL on December 1. Live and archived webcasts of the fireside chats will be available on the company’s investor relations website. Absci, a clinical-s...
10-27 12:00
Keybanc Maintains Overweight on Absci, Raises Price Target to $20
Keybanc analyst Scott Schoenhaus maintains Absci (NASDAQ:ABSI) with a Overweight and raises the price target from $16 to $20.
10-16 21:16
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Friday. Shares of Humana Inc (NYSE:HUM) rose sharply after the company said Friday that its 2027 Medicare Advantage Star Ratings improved significantly, with 95% of members enrolled in plans earning at least four stars f...
10-09 22:51
美股大行评级 | 汽车地带绩后遭10家机构降目标价！最低看至3000美元；美光、微软、Meta齐获看多
今日重点评级关注：Leerink Partners：维持塞德斯医疗"跑赢大市"评级，目标价从70美元升至88美元；HC Wainwright & Co.：维持TriSalus Life Sciences"买入"评级，目标价从11美元升至12美元
09-24 16:10
